Publications by authors named "G W Yin"
Silver chalcogenides exhibit exceptional transport properties but face structural instability at high temperatures, limiting their practical applications. Using AgTe as a model, it is confirm that silver whisker growth above the phase transition renders AgTe unsuitable for thermoelectric applications. Here, the whisker growth mechanism is investigated and propose an inhibition strategy, overcoming a major obstacle in using silver chalcogenides.
View Article and Find Full Text PDFPurpose: The combination therapy of lenvatinib and immunotherapy as first-line treatment remains controversial in unresectable hepatocellular carcinoma (uHCC). This research aimed to compare the efficacy and safety of lenvatinib monotherapy (L) and combination therapy of lenvatinib and immune checkpoint inhibitor (LI) in lenvatinib-insensitive patients with uHCC.
Methods: Two hundred fifty-five uHCC patients were enrolled in this study.
To investigate the clinicopathological characteristics, immunophenotypes, diagnostic criteria and differential diagnosis of atrophic kidney-like lesion (AKLL). Three cases of AKLL were collected from April 2021 to October 2023 at the Xiangya Hospital of Central South University, Changsha, Zhejiang Provincial People's Hospital, Hangzhou and Ningbo Clinical Pathology Diagnosis Center, Ningbo, China. The clinical, morphological, and immunohistochemical characteristics were analyzed.
View Article and Find Full Text PDFArticle Synopsis
- Polylactic acid (PLA) is an environmentally friendly polymer that biodegrades and is made from renewable resources, making it a strong alternative to traditional plastics.
- PLA is biocompatible and non-toxic, which improves safety in medical applications by minimizing tissue reactions and eliminating the need for additional surgeries due to its natural breakdown.
- Recent advancements in nanotechnology and 3D printing have enhanced PLA’s structural and biological properties, expanding its use in drug delivery systems, orthopedic treatments, tissue engineering, and medical devices.
Background & Aims: Current prognostic models for patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) are not extensively validated and widely accepted. We aimed to develop and validate a continuous model incorporating tumor burden and biology for individual survival prediction and risk stratification.
Methods: Overall, 4,377 treatment-naive candidates for whom TACE was recommended, from 39 centers in five countries, were enrolled and divided into training, internal validation, and two external validation datasets.